Skip to main content
. Author manuscript; available in PMC: 2012 Mar 1.
Published in final edited form as: Nat Rev Endocrinol. 2010 Nov 16;7(3):137–150. doi: 10.1038/nrendo.2010.199

Figure 1. Fat Redistribution in HIV-infected patients on HAART.

Figure 1

A. Buffalo hump and increased abdominal adiposity in a patient with HALS. Courtesy of A.W. Karchmer, C.S. Mantzoros, and S. Tsiodras. Image from Leow et al199, Copyright © 2003, The Endocrine Society.

B. Loss of extremity fat and increased abdominal girth in a patient with HALS. Courtesy of A.W. Karchmer, C.S. Mantzoros, and S. Tsiodras. Image from Leow et al,199 Copyright © 2003, The Endocrine Society.

C. Dual-energy x-ray absorptiometry (DEXA) scan indicating regions of interest for body composition analyses. Image from Grinspoon and Carr200, Copyright © 2005 Massachusetts Medical Society. All rights reserved.

D. Abdominal CT scan showing hepatomegaly in a patient with HALS. Courtesy of CS Mantzoros, Beth Israel Deaconess Medical Center (Boston, MA). Image from Leow et al199, Copyright © 2003, The Endocrine Society.

E. Change in truncal and limb fat over time in a patient with HALS. Truncal fat increases and limb fat decreases as a result of HAART. Leptin treatment commencing at week 13 begins to reverse pathological changes in fat distribution. Courtesy of C.S. Mantzoros.